US Stock MarketDetailed Quotes

NAMS NewAmsterdam Pharma

Watchlist
  • 25.890
  • -0.720-2.71%
Close Dec 18 16:00 ET
  • 26.640
  • +0.750+2.90%
Pre 08:01 ET
2.71BMarket Cap-11.71P/E (TTM)

NewAmsterdam Pharma Key Stats

NewAmsterdam Pharma Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 5 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: EUR

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
--2025/Q1-- / 3.334M--
--2024/Q4-- / 1.626M--
--2024/Q327.126M / 1.705M--
--2024/Q22.085M / 1.109M--
--2024/Q11.304M / 1.607M--
DatePeriodRevenue/EstimateEarnings Call
--2025/Q1-- / 3.334M--
--2024/Q4-- / 1.626M--
--2024/Q327.126M / 1.705M--
--2024/Q22.085M / 1.109M--
--2024/Q11.304M / 1.607M--

Unlock Free Earnings Estimates

NewAmsterdam Pharma Earnings Reports

Read more

Trending US Stocks
Best Growth Stocks Best Growth Stocks

Spot stocks with huge growth potential and solid financial standing. Spot stocks with huge growth potential and solid financial standing.

Analysis

Analyst Rating

Updated: Dec 11, 2024

Strong Buy

  • Buy

    100.00%
  • Hold

    0.00%
  • Sell

    0.00%

Price Target

No Data